Abstract
Background The 3q29 deletion syndrome (DS) is a copy number variant (CNV) with the highest known effect size for psychosis-risk (>40-fold increased risk). Systematic research on this CNV offers promising avenues for identifying mechanisms underlying psychosis and related disorders. Relative to other high-impact CNVs like 22q11.2DS, far less is known about the phenotypic presentation and pathophysiology of 3q29DS. Emerging findings indicate that posterior fossa abnormalities are common in 3q29DS; however, their clinical relevance is unknown.
Methods Here, we report the first in-depth evaluation of psychotic symptoms in study subjects with 3q29DS (N=23), using the Structured Interview for Psychosis-Risk Syndromes (SIPS), and compare to SIPS data from 22q11.2DS participants (N=31) and healthy controls (N=279). We also investigate the relationship between psychotic symptoms, cerebellar morphology, and cystic/cyst-like malformations of the posterior fossa in 3q29DS by structural brain imaging.
Results Cumulatively, 48% of the 3q29DS sample exhibited a psychotic disorder or attenuated positive symptoms. Among 3q29DS individuals with attenuated symptoms, 43% met the frequency and timing criteria for a formal attenuated psychotic symptom syndrome. Males with 3q29DS scored higher in negative symptoms than females. 3q29DS participants had more severe ratings than controls on all domains and exhibited less severe negative symptoms than 22q11.2DS participants. An inverse relationship was identified between positive symptom severity and cerebellar cortex volume in 3q29DS, while cystic/cyst-like malformations yielded no clinical link with psychosis.
Conclusions Overall, our findings establish the unique and shared profiles of psychotic symptoms across two CNVs and highlight cerebellar involvement in elevated psychosis-risk in 3q29DS.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this work was provided by National Institutes of Health (NIH) grants R01 MH110701, R01 MH118534, and National Institutes of Mental Health (NIMH) grant U01MH081988. REDCap is supported by grant UL1 TR000424. Funding for work in 22q11.2DS was provided by grants awarded to Joseph Cubells and Opal Ousley from the Robert W. Woodruff Fund and the Predictive Health Initiative of Emory University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board of Emory University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The 3q29DS data collected in this study are deposited in the NIMH Data Archive (nda.nih.gov) (behavioral data: collection 2614, embargoed until September 2022; neuroimaging data: collection 3126, embargoed until November 2023). Prior to these dates, the 3q29DS data are available from the corresponding author upon reasonable request. The NAPLS2 data used in this article are available from Elaine F. Walker on behalf of the NAPLS Consortium upon reasonable request. The 22q11.2DS data used in this article are available from Opal Ousley and Joseph F. Cubells upon reasonable request.